TY - JOUR
T1 - Psychological distress and alcohol use disorder during the COVID-19 era among middle- and low-income U.S. adults
AU - Tsai, Jack
AU - Elbogen, Eric B.
AU - Huang, Minda
AU - North, Carol S.
AU - Pietrzak, Robert H.
N1 - Funding Information:
Financial support was provided by internal university funds from the University of Texas Health Science Center at Houston.
Publisher Copyright:
© 2021
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Purpose: This study examined how exposure to events during the Coronavirus Disease-19 (COVID-19) era is linked to symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), COVID-19 era-related stress (CS), alcohol use disorder (AUD), and suicidal ideation (SI) in low and middle-income U.S adults. Methods: A national sample of 6,607 adults (4.4% who reported testing positive for COVID-19, 25.3% testing negative, and 70.3% untested) were recruited an online platform andcompleted the Patient Health Questionnaire-2, Generalized Anxiety Disorder-2, PTSD-Checklist for DSM-5, the Alcohol Use Disorder Identification-Consumption scale, and an item assessing SI in May-June 2020. A series of multivariable analyses were conducted. Results: In the total sample, 35.3% screened positive for current AUD, 33.6% for MDD, 33.6% for GAD, 24.6% for SI, and 20.2% for CS. Past 2-week SI (adjusted odds ratios [AORs]= 1.49–12.06), number of close friends (AORs= 1.40–2.72), history of AUD (AORs= 1.15–1.92), history of anxiety disorder (AORs= 1.07–2.63), and younger age (AORs= 0.97–0.98) were significantly associated with screening positive for MDD, GAD, CS, and AUD. COVID-19 status was not independently associated with these conditions, but the combination of testing positive for COVID-19, meeting criteria for AUD, and screening positive for MDD, GAD, or CS predicted a 96% probability for SI. Conclusion: Predisposing factors are stronger predictors of psychological distress than personal COVID-19 infection or exposure. The additive effects of COVID-19 infection, alcohol use, and psychiatric problems in predicting SI suggest screening, monitoring, and treating these conditions in population-based prevention and treatment efforts may be important.
AB - Purpose: This study examined how exposure to events during the Coronavirus Disease-19 (COVID-19) era is linked to symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), COVID-19 era-related stress (CS), alcohol use disorder (AUD), and suicidal ideation (SI) in low and middle-income U.S adults. Methods: A national sample of 6,607 adults (4.4% who reported testing positive for COVID-19, 25.3% testing negative, and 70.3% untested) were recruited an online platform andcompleted the Patient Health Questionnaire-2, Generalized Anxiety Disorder-2, PTSD-Checklist for DSM-5, the Alcohol Use Disorder Identification-Consumption scale, and an item assessing SI in May-June 2020. A series of multivariable analyses were conducted. Results: In the total sample, 35.3% screened positive for current AUD, 33.6% for MDD, 33.6% for GAD, 24.6% for SI, and 20.2% for CS. Past 2-week SI (adjusted odds ratios [AORs]= 1.49–12.06), number of close friends (AORs= 1.40–2.72), history of AUD (AORs= 1.15–1.92), history of anxiety disorder (AORs= 1.07–2.63), and younger age (AORs= 0.97–0.98) were significantly associated with screening positive for MDD, GAD, CS, and AUD. COVID-19 status was not independently associated with these conditions, but the combination of testing positive for COVID-19, meeting criteria for AUD, and screening positive for MDD, GAD, or CS predicted a 96% probability for SI. Conclusion: Predisposing factors are stronger predictors of psychological distress than personal COVID-19 infection or exposure. The additive effects of COVID-19 infection, alcohol use, and psychiatric problems in predicting SI suggest screening, monitoring, and treating these conditions in population-based prevention and treatment efforts may be important.
KW - Alcohol use disorder
KW - Epidemiology
KW - Mental illness
KW - Suicide
UR - http://www.scopus.com/inward/record.url?scp=85103785159&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103785159&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2021.03.085
DO - 10.1016/j.jad.2021.03.085
M3 - Article
C2 - 33839557
AN - SCOPUS:85103785159
SN - 0165-0327
VL - 288
SP - 41
EP - 49
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -